Back

Equity Impacts of Dollar Store Vaccine Distribution

Chevalier, J. A.; Schwartz, J. L.; Su, Y. S.; Williams, K. R.

2021-04-05 health economics
10.1101/2021.04.03.21254847
Show abstract

We use geospatial data to examine the unprecedented national program currently underway in the United States to distribute and administer vaccines against COVID-19. We quantify the impact of the proposed federal partnership with the company Dollar General to serve as vaccination sites and compare vaccine access with Dollar General to the current Federal Retail Pharmacy Partnership Program. Although dollar stores have been viewed with skepticism and controversy in the policy sector, we show that, relative to the locations of the current federal program, Dollar General stores are disproportionately likely to be located in Census tracts with high social vulnerability; using these stores as vaccination sites would greatly decrease the distance to vaccines for both low-income and minority households. We consider a hypothetical alternative partnership with Dollar Tree and show that adding these stores to the vaccination program would be similarly valuable, but impact different geographic areas than the Dollar General partnership. Adding Dollar General to the current pharmacy partners greatly surpasses the goal set by the Biden administration of having 90% of the population within 5 miles of a vaccine site. We discuss the potential benefits of leveraging these partnerships for other vaccinations, including against influenza.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Proceedings of the National Academy of Sciences
based on 100 papers
Top 0.1%
17.9%
2
PLOS ONE
based on 1737 papers
Top 48%
10.7%
3
American Journal of Preventive Medicine
based on 11 papers
Top 0.1%
8.0%
4
Journal of Medical Economics
based on 10 papers
Top 0.1%
8.0%
5
Nature Communications
based on 483 papers
Top 12%
6.7%
50% of probability mass above
6
npj Digital Medicine
based on 85 papers
Top 7%
2.6%
7
JAMA Network Open
based on 125 papers
Top 7%
2.6%
8
PLOS Global Public Health
based on 287 papers
Top 13%
2.4%
9
Clinical Infectious Diseases
based on 219 papers
Top 11%
2.4%
10
BMC Public Health
based on 148 papers
Top 11%
2.4%
11
Scientific Reports
based on 701 papers
Top 62%
2.4%
12
Nature
based on 58 papers
Top 3%
2.4%
13
Journal of Theoretical Biology
based on 29 papers
Top 1%
1.9%
14
Journal of Medical Internet Research
based on 81 papers
Top 9%
1.7%
15
Journal of The Royal Society Interface
based on 54 papers
Top 2%
1.7%
16
Social Science & Medicine
based on 15 papers
Top 1%
1.4%
17
Preventive Medicine Reports
based on 14 papers
Top 1.0%
1.3%
18
BMJ Open
based on 553 papers
Top 46%
1.3%
19
Vaccine
based on 140 papers
Top 4%
1.3%
20
BMC Health Services Research
based on 43 papers
Top 4%
0.8%
21
Frontiers in Public Health
based on 135 papers
Top 27%
0.7%
22
American Journal of Epidemiology
based on 54 papers
Top 7%
0.7%
23
Scientific Data
based on 30 papers
Top 4%
0.7%
24
PLOS Computational Biology
based on 141 papers
Top 10%
0.7%
25
Emerging Infectious Diseases
based on 84 papers
Top 12%
0.7%